BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $173.74 million. The enterprise value is $105.39 million.
Important Dates
The last earnings date was Tuesday, March 11, 2025, before market open.
| Earnings Date | Mar 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 38.70 million shares outstanding. The number of shares has decreased by -2.11% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 38.70M |
| Shares Change (YoY) | -2.11% |
| Shares Change (QoQ) | +16.92% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 24.09M |
Valuation Ratios
The trailing PE ratio is 59.48 and the forward PE ratio is 33.92.
| PE Ratio | 59.48 |
| Forward PE | 33.92 |
| PS Ratio | 4.24 |
| Forward PS | 0.93 |
| PB Ratio | 2.79 |
| P/TBV Ratio | 2.79 |
| P/FCF Ratio | 26.70 |
| P/OCF Ratio | 16.98 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 34.11, with an EV/FCF ratio of 16.19.
| EV / Earnings | 36.08 |
| EV / Sales | 2.57 |
| EV / EBITDA | 34.11 |
| EV / EBIT | 75.76 |
| EV / FCF | 16.19 |
Financial Position
The company has a current ratio of 5.31
| Current Ratio | 5.31 |
| Quick Ratio | 4.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0.92 |
Financial Efficiency
Return on equity (ROE) is 5.62% and return on invested capital (ROIC) is 1.67%.
| Return on Equity (ROE) | 5.62% |
| Return on Assets (ROA) | 1.11% |
| Return on Invested Capital (ROIC) | 1.67% |
| Return on Capital Employed (ROCE) | 1.76% |
| Revenue Per Employee | $306,090 |
| Profits Per Employee | $21,799 |
| Employee Count | 134 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.56 |
Taxes
In the past 12 months, BrainsWay has paid $538,000 in taxes.
| Income Tax | 538,000 |
| Effective Tax Rate | 15.55% |
Stock Price Statistics
The stock price has increased by +77.14% in the last 52 weeks. The beta is 0.44, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +77.14% |
| 50-Day Moving Average | 10.25 |
| 200-Day Moving Average | 8.87 |
| Relative Strength Index (RSI) | 39.14 |
| Average Volume (20 Days) | 56,794 |
Short Selling Information
| Short Interest | 125,099 |
| Short Previous Month | 55,261 |
| Short % of Shares Out | 0.92% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.36 |
Income Statement
In the last 12 months, BrainsWay had revenue of $41.02 million and earned $2.92 million in profits. Earnings per share was $0.09.
| Revenue | 41.02M |
| Gross Profit | 30.58M |
| Operating Income | 1.39M |
| Pretax Income | 778,000 |
| Net Income | 2.92M |
| EBITDA | 3.09M |
| EBIT | 1.39M |
| Earnings Per Share (EPS) | $0.09 |
Full Income StatementBalance Sheet
The company has $69.35 million in cash and n/a in debt, giving a net cash position of $69.35 million or $1.79 per share.
| Cash & Cash Equivalents | 69.35M |
| Total Debt | n/a |
| Net Cash | 69.35M |
| Net Cash Per Share | $1.79 |
| Equity (Book Value) | 62.31M |
| Book Value Per Share | 1.61 |
| Working Capital | 64.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $10.23 million and capital expenditures -$3.72 million, giving a free cash flow of $6.51 million.
| Operating Cash Flow | 10.23M |
| Capital Expenditures | -3.72M |
| Free Cash Flow | 6.51M |
| FCF Per Share | $0.17 |
Full Cash Flow StatementMargins
Gross margin is 74.56%, with operating and profit margins of 3.39% and 7.12%.
| Gross Margin | 74.56% |
| Operating Margin | 3.39% |
| Pretax Margin | 8.43% |
| Profit Margin | 7.12% |
| EBITDA Margin | 7.53% |
| EBIT Margin | 3.39% |
| FCF Margin | 15.87% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.11% |
| Shareholder Yield | 2.11% |
| Earnings Yield | 1.68% |
| FCF Yield | 3.75% |
Analyst Forecast
The average price target for BrainsWay is $13.17, which is 42.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.17 |
| Price Target Difference | 42.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BrainsWay has an Altman Z-Score of 2.2 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.2 |
| Piotroski F-Score | 6 |